Abbott Laboratories: director Nita Ahuja received 318 shares

What happened Nita Ahuja, a director, received 318 shares as an award or other acquisition (derivative) at $98.83 per share on Sep 30, 2026, for $31,428 in the Form 4 filing.

Key details

• Transaction date and code: Sep 30, 2026 — grant/award or other acquisition (Code A) of 318 shares @ $98.83.
• Shares owned after the transaction: not specified in the filing.
• Footnote F1: director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board; the stock equivalent units earn the same return as if the fees were invested in Abbott shares.
• Footnote F2: balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.
• Filing date: Oct 2, 2026; the filing does not indicate it was late.

Why it may matter The filing shows a director award of derivative shares (stock equivalent units), not a market purchase or sale. The filing does not show why the insider traded or why the company acted.